期刊文献+

ICU内嗜麦芽窄食单胞菌感染的高危因素和临床分析 被引量:7

Risk factors of stenotrophomonas maltophilia infection in ICU
下载PDF
导出
摘要 目的研究重症监护病房(ICu)中嗜麦芽窄食单胞菌感染的临床、药敏和细菌学特点。方法回顾性分析ICU中112例院内嗜麦芽窄食单胞菌感染病例。结果嗜麦芽窄食单胞菌具有多重耐药的特性,对亚胺培南100%耐药,对复方磺胺甲噁唑、环丙沙星敏感性较高,侵入性操作、高龄、长期住院、广谱抗生素的长期使用是主要的高危因素。结论减少侵入性操作和广谱抗生素的长期使用,根据药敏选择抗生素,能减少嗜麦芽窄食单胞菌感染的发生。 Objective To study the distribution, antimicrobial susceptibility, clinical and bacteriological characteristics of stenotrophomonas mahophilia infection. Methods 112 cases in ICU infected with stenotrophomonas maltophilia were analyzed retrospectively. Result The bacterium was resistant to most antibiotics, the resistant rate of imipenem was 100%. The sensitive rate of stenotrophomonas mahophilia to trimcthoprim/sulfamethoxazole was the highest about 65% , followed by ciprofloxacin 55.3%. Invasive operation, the elderly, hospitalization clays and the abuse of broad - spectrum antibiotics were risk factors of infection with stenotrophomonas maltophilla. Conclusion The patients in ICU should be avoided the abuse of broad - spectrum antibiotics for a long time and invasive operation. Bacterial culture and antibiotic susceptibility test must be carried out promptly. That can reduce the incidence of stenotrophomonas mahophilia infection.
出处 《中国急救医学》 CAS CSCD 北大核心 2006年第12期906-908,共3页 Chinese Journal of Critical Care Medicine
关键词 嗜麦芽窄食单胞菌 耐药性 高危因素 Stenotrophomonas mahophilia Drug resistance Risk factor
  • 相关文献

参考文献6

二级参考文献62

  • 1汪海刚,赵江敏,李珍大,宗永兰,邵海枫.嗜麦芽假单胞菌对抗菌药物的敏感试验[J].临床检验杂志,1995,13(3):147-148. 被引量:13
  • 2马明国,王建,王雪梅.基于遥感的植被年际变化及其与气候关系研究进展[J].遥感学报,2006,10(3):421-431. 被引量:215
  • 3蔡运龙.中国西南岩溶石山贫困地区的生态重建[J].地球科学进展,1996,11(6):602-606. 被引量:148
  • 4Denny BJ, Lambert PA, West PW. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia. FEMS Microbiol Lett, 2002,208 ( 1 ) : 21-24.
  • 5Valdezate S, Vindel A, Loza E,et al. Topoisomerase Ⅱ and Ⅳ quinolong resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother, 2002,46 ( 3 ) : 665.
  • 6Ribera A, Domenech SA, Ruiz J, et al. Mutation in gyrA and parC QRDRs are not relavant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates. Microb Drug Resist,2002,8(4) :245-251.
  • 7Zhang L,Li XZ, Poole,Keith. Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa,Stenotrophomonas maltophilia and Burkholderia cepacia. Journal of Antimicrobial Chemotherapy,2001,48(4) :549-552.
  • 8Ribera A,Jurado A, Ruiz J,et al. In vitro activity of clinafloxaein in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine. Diagn Microbiol Infect Dis,2002,42(2) :123-128.
  • 9Li XZ, Zhang L, McKay GA, et al. Role of acetyltransferase AAC(6 ')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimierob Chemother, 2003,51(4) :803-811.
  • 10Barbier FN, Boutiba BI, Nouvello M, et al. Stenotrophomonas maltophilia D457R contains a cluster of genes from molecular instigation of Stenotrophomonas maltophilia isolates exhibiting rapid emergence of ticarcillin-clavulanate resistance. J Hosp Infect, 2000,45 : 35.

共引文献81

同被引文献54

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部